Tweets
- Tweets, current page.
- Tweets & replies
- Media
You blocked @Xconomy
Are you sure you want to view these Tweets? Viewing Tweets won't unblock @Xconomy
-
Pinned Tweet
Sign up for our new free newsletters for industry news, insight, and analysis: https://mailchi.mp/xconomy.com/subscribe-twitter-profile …
#Xconomists#XconXpertise#XconBioRoundup#XcelerateLS#XconSD#XconSF#XconNY#XconBOS#XconSEA#XconPHIpic.twitter.com/BW5Oav6cRA
Thanks. Twitter will use this to make your timeline better. UndoUndo -
BIO Report: More Work Needed to Improve Diversity at Biotech Firms - by
@sarahdchttps://xconomy.com/national/2020/01/30/bio-report-more-work-needed-to-improve-diversity-at-biotech-firms/ …Thanks. Twitter will use this to make your timeline better. UndoUndo -
Xconomy Retweeted
When it comes to
#CRISPR, size matters. Here's why@mammothbiosci thinks the smaller size of Cas14 gives it advantages for developing new drugs and diagnosticshttps://xconomy.com/san-francisco/2020/01/30/with-45m-mammoth-bio-expects-big-things-from-tiny-crispr-cas14/ …Thanks. Twitter will use this to make your timeline better. UndoUndo -
[PARTNER EVENT]
@NYCHBL presents 7th annual Healthcare Investment Trends: Where Will the Money Flow in 2020? Use code HCVC-PARTNER for $25 discount on registration. REGISTER: http://bit.ly/hcvc2020partner Sponsored by@BDOhealth#HCVC2020Thanks. Twitter will use this to make your timeline better. UndoUndo -
Newly added
#XconSD#XcelerateLS speakers include: Ciara Kennedy of@AmplyxPharma Chris Loryman of@UCSDInnovation Russ Barrans of@Evofem Josh Schimmer of Evercore https://xconomy.com/xcelerating-life-sciences-san-diego/ …pic.twitter.com/8zp9PZHaJx
Thanks. Twitter will use this to make your timeline better. UndoUndo -
With $45M,
@mammothbiosci Expects Big Things From Tiny CRISPR Cas14 - by@frankvinluan; insight from CEO@martintrevor_https://xconomy.com/san-francisco/2020/01/30/with-45m-mammoth-bio-expects-big-things-from-tiny-crispr-cas14/ …Thanks. Twitter will use this to make your timeline better. UndoUndo -
Black Diamond’s Upsized IPO Raises $201M to Advance Its Cancer Drug R&D - by
@frankvinluan https://xconomy.com/boston/2020/01/30/black-diamonds-upsized-ipo-raises-201m-to-advance-its-cancer-drug-rd/ …$BDTXThanks. Twitter will use this to make your timeline better. UndoUndo -
Vizgen Launches With $14M to Market New Subcellular Imaging Technique - by
@sarahdchttps://xconomy.com/boston/2020/01/30/vizgen-launches-with-14m-to-market-new-subcellular-imaging-technique/ …Thanks. Twitter will use this to make your timeline better. UndoUndo -
Spun out the
#XconomyAwards where Nancy Hopkins won the Lifetime Achievement Award, 3@MIT scientists formed the Boston Biotech Working Group to "remedy the gender imbalance in biotech": https://www.statnews.com/2020/01/29/biotechs-missing-women/ …@snbhatia@SusanHockfieldThanks. Twitter will use this to make your timeline better. UndoUndo -
Annovis Bio Gets $12M in IPO to Target Trio of Neurotoxic Proteins - by
@sarahdc https://xconomy.com/new-york/2020/01/29/annovis-bio-gets-12m-in-ipo-to-target-trio-of-neurotoxic-proteins/ …$ANVSThanks. Twitter will use this to make your timeline better. UndoUndo -
Xconomy Retweeted
Lack of good
#CDMOs a factor for@KrystalBiotech in investing $70-90m into internal PA gene therapy plant https://buff.ly/2Obgc1e pic.twitter.com/wqhhN650eL
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Xconomy Retweeted
Calling all
#Starups
Are you looking to engage with #biopharma executives and#investors? Apply to pitch at this year’s Startup Spotlight during#BIOEuropeSpring. The deadline to apply is this Friday, January 31! >> http://ebdgroup.formstack.com/forms/?3673559-bQOQpjzsfb&_ga=2.175469154.1150738558.1580094181-1440400942.1556918554&_gac=1.11323136.1577985105.EAIaIQobChMI9ZCDyrTl5gIVGKSzCh3rPg5eEAAYASAAEgLGOPD_BwE …pic.twitter.com/EL0sfhPySc
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Xconomy Retweeted
This
@AcceleronPharma drug didn't pan out treating a rare blood disorder or chronic kidney disease. But with positive topline Phs 2 data in#pulmonaryarterialhypertension, some now see blockbuster potential.$XLRN shares shot up 50% Tues. https://xconomy.com/boston/2020/01/28/third-times-the-charm-as-acceleron-drug-shows-early-promise-in-pah/ …#PAHThanks. Twitter will use this to make your timeline better. UndoUndo -
Xconomy Retweeted
When developing a new therapy how do you keep in complete control of its manufacturing? This whitepaper looks at what to consider - whatever path you take.http://spr.ly/601015Ham
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Xconomy Retweeted
Attend the 14th Annual Hub and SPP Model Optimization event, which will feature manufacturers, pharmacies, PBMs and more, on February 24-26, 2020, at the Loews Philadelphia Hotel. Register today!
@InformaConnect#conferencehttps://informaconnect.com/hub-and-spp-model-optimization/ …Thanks. Twitter will use this to make your timeline better. UndoUndo -
.
@SpringBankPharm Ends Hepatitis B Work After Death in Clinical Trial - by@frankvinluan https://xconomy.com/boston/2020/01/29/spring-bank-pharma-ends-hepatitis-b-work-after-death-in-clinical-trial/ …$SBPHThanks. Twitter will use this to make your timeline better. UndoUndo -
Agenda and Speakers Announced for Xcelerating Life Sciences San Diego: https://xconomy.com/national/2020/01/29/agenda-and-speakers-announced-for-xcelerating-life-sciences-san-diego/ …
#XconSD#XcelerateLSpic.twitter.com/Ye1bgcp8nr
Thanks. Twitter will use this to make your timeline better. UndoUndo -
.
@DecibelTx Strikes a Balance, Adding Regenerative Med Focus +@laurence_reid is new acting CEO - by@frankvinluanhttps://xconomy.com/boston/2020/01/29/decibel-therapeutics-strikes-a-balance-adding-regenerative-med-focus/ …Thanks. Twitter will use this to make your timeline better. UndoUndo -
Histogen (-> Conatus), Timber Pharma (->
@biopharmx) Plan Reverse Mergers to Join Public Markets - by@sarahdc https://xconomy.com/san-diego/2020/01/28/histogen-timber-pharma-plan-reverse-mergers-to-join-public-markets/ …$CNAT$BPMXThanks. Twitter will use this to make your timeline better. UndoUndo -
Third Time’s the Charm as
@Acceleron Drug Shows Early Promise in PAH - by@frankvinluan https://xconomy.com/boston/2020/01/28/third-times-the-charm-as-acceleron-drug-shows-early-promise-in-pah/ …$XLRNThanks. Twitter will use this to make your timeline better. UndoUndo -
Xconomy Retweeted
BioIntelliSense Debuts “Sticker” Sensor to Capture Patient Data Remotely https://xconomy.com/boulder-denver/2020/01/28/biointellisense-debuts-sticker-sensor-to-capture-patient-data-remotely/ … via
@xconomyThanks. Twitter will use this to make your timeline better. UndoUndo
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.